Abpro Bio Co., Ltd. (KOSDAQ:195990)

Abpro Bio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr 23, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	42,739	74,019	128,110	155,155	115,496	244,023
Market Cap Growth	-48.23%	-42.22%	-17.43%	34.34%	-52.67%	-47.12%
Enterprise Value	53,161	83,458	112,040	146,682	101,187	216,105
Last Close Price	1312.00	2600.00	4500.00	5450.00	4220.00	9650.00
Forward PE	-	4.78	4.78	4.78	4.78	4.78
PS Ratio	1.34	2.32	4.05	6.11	5.22	7.41
PB Ratio	0.79	1.37	1.19	1.27	0.82	1.77
P/TBV Ratio	1.02	1.77	1.41	1.40	0.84	1.82
EV/Sales Ratio	1.67	2.61	3.54	5.78	4.58	6.57
Debt / Equity Ratio	0.29	0.29	0.20	0.10	0.08	0.16
Net Debt / Equity Ratio	0.19	0.19	0.00	-0.07	-0.08	-0.24
Net Debt / EBITDA Ratio	-1.37	-1.37	-0.08	0.97	1.11	12.03
Net Debt / FCF Ratio	-1.21	-1.21	-0.02	1.34	0.87	11.80
Asset Turnover	0.30	0.30	0.22	0.17	0.14	0.20
Inventory Turnover	2.10	2.10	2.07	1.38	1.21	2.08
Quick Ratio	1.12	1.12	1.55	1.39	1.59	1.97
Current Ratio	3.22	3.22	2.33	2.50	2.86	2.75
Return on Equity (ROE)	-60.38%	-60.38%	-13.57%	-19.61%	-5.87%	-7.06%
Return on Assets (ROA)	-5.37%	-5.37%	-2.89%	-4.26%	-4.31%	-2.00%
Return on Invested Capital (ROIC)	-13.78%	-10.73%	-5.88%	-8.36%	-9.56%	-4.77%
Return on Capital Employed (ROCE)	-14.00%	-14.00%	-5.40%	-8.20%	-8.00%	-3.90%
Earnings Yield	-114.46%	-66.09%	-12.20%	-16.59%	-7.05%	-4.11%
FCF Yield	-20.12%	-11.62%	-17.84%	-3.87%	-10.90%	-1.13%
Buyback Yield / Dilution	0.00%	0.00%	-923.05%	-3.72%	0.50%	-25.82%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.